Identification by cluster analysis of patients with asthma and nasal symptoms using the MASK-air® mHealth app
The self-reporting of asthma frequently leads to patient misidentification in epidemiological studies. Strategies combining the triangulation of data sources may help to improve the identification of people with asthma. We aimed to combine information from the self-reporting of asthma, medication us...
Uloženo v:
| Vydáno v: | Pediatric pulmonology Ročník 29; číslo 4; s. 292 - 305 |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
Spain
Elsevier España, S.L.U
01.07.2023
Wiley Elsevier Espana S.L.U Taylor & Francis Group |
| Témata: | |
| ISSN: | 2531-0437, 2531-0429, 8755-6863, 2531-0437, 1099-0496 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | The self-reporting of asthma frequently leads to patient misidentification in epidemiological studies. Strategies combining the triangulation of data sources may help to improve the identification of people with asthma. We aimed to combine information from the self-reporting of asthma, medication use and symptoms to identify asthma patterns in the users of an mHealth app.
We studied MASK-air® users who reported their daily asthma symptoms (assessed by a 0-100 visual analogue scale – “VAS Asthma”) at least three times (either in three different months or in any period). K-means cluster analysis methods were applied to identify asthma patterns based on: (i) whether the user self-reported asthma; (ii) whether the user reported asthma medication use and (iii) VAS asthma. Clusters were compared by the number of medications used, VAS asthma levels and Control of Asthma and Allergic Rhinitis Test (CARAT) levels.
We assessed a total of 8,075 MASK-air® users. The main clustering approach resulted in the identification of seven groups. These groups were interpreted as probable: (i) severe/uncontrolled asthma despite treatment (11.9-16.1% of MASK-air® users); (ii) treated and partly-controlled asthma (6.3-9.7%); (iii) treated and controlled asthma (4.6-5.5%); (iv) untreated uncontrolled asthma (18.2-20.5%); (v) untreated partly-controlled asthma (10.1-10.7%); (vi) untreated controlled asthma (6.7-8.5%) and (vii) no evidence of asthma (33.0-40.2%). This classification was validated in a study of 192 patients enrolled by physicians.
We identified seven profiles based on the probability of having asthma and on its level of control. mHealth tools are hypothesis-generating and complement classical epidemiological approaches in identifying patients with asthma. |
|---|---|
| AbstractList | Background The self-reporting of asthma frequently leads to patient misidentification in epidemiological studies. Strategies combining the triangulation of data sources may help to improve the identification of people with asthma. We aimed to combine information from the self-reporting of asthma, medication use and symptoms to identify asthma patterns in the users of an mHealth app.Methods We studied MASK-air® users who reported their daily asthma symptoms (assessed by a 0-100 visual analogue scale – “VAS Asthma”) at least three times (either in three different months or in any period). K-means cluster analysis methods were applied to identify asthma patterns based on: (i) whether the user self-reported asthma; (ii) whether the user reported asthma medication use and (iii) VAS asthma. Clusters were compared by the number of medications used, VAS asthma levels and Control of Asthma and Allergic Rhinitis Test (CARAT) levels.Findings We assessed a total of 8,075 MASK-air® users. The main clustering approach resulted in the identification of seven groups. These groups were interpreted as probable: (i) severe/uncontrolled asthma despite treatment (11.9-16.1% of MASK-air® users); (ii) treated and partly-controlled asthma (6.3-9.7%); (iii) treated and controlled asthma (4.6-5.5%); (iv) untreated uncontrolled asthma (18.2-20.5%); (v) untreated partly-controlled asthma (10.1-10.7%); (vi) untreated controlled asthma (6.7-8.5%) and (vii) no evidence of asthma (33.0-40.2%). This classification was validated in a study of 192 patients enrolled by physicians.Interpretation We identified seven profiles based on the probability of having asthma and on its level of control. mHealth tools are hypothesis-generating and complement classical epidemiological approaches in identifying patients with asthma. The self-reporting of asthma frequently leads to patient misidentification in epidemiological studies. Strategies combining the triangulation of data sources may help to improve the identification of people with asthma. We aimed to combine information from the self-reporting of asthma, medication use and symptoms to identify asthma patterns in the users of an mHealth app. We studied MASK-air® users who reported their daily asthma symptoms (assessed by a 0-100 visual analogue scale – “VAS Asthma”) at least three times (either in three different months or in any period). K-means cluster analysis methods were applied to identify asthma patterns based on: (i) whether the user self-reported asthma; (ii) whether the user reported asthma medication use and (iii) VAS asthma. Clusters were compared by the number of medications used, VAS asthma levels and Control of Asthma and Allergic Rhinitis Test (CARAT) levels. We assessed a total of 8,075 MASK-air® users. The main clustering approach resulted in the identification of seven groups. These groups were interpreted as probable: (i) severe/uncontrolled asthma despite treatment (11.9-16.1% of MASK-air® users); (ii) treated and partly-controlled asthma (6.3-9.7%); (iii) treated and controlled asthma (4.6-5.5%); (iv) untreated uncontrolled asthma (18.2-20.5%); (v) untreated partly-controlled asthma (10.1-10.7%); (vi) untreated controlled asthma (6.7-8.5%) and (vii) no evidence of asthma (33.0-40.2%). This classification was validated in a study of 192 patients enrolled by physicians. We identified seven profiles based on the probability of having asthma and on its level of control. mHealth tools are hypothesis-generating and complement classical epidemiological approaches in identifying patients with asthma. The self-reporting of asthma frequently leads to patient misidentification in epidemiological studies. Strategies combining the triangulation of data sources may help to improve the identification of people with asthma. We aimed to combine information from the self-reporting of asthma, medication use and symptoms to identify asthma patterns in the users of an mHealth app.BACKGROUNDThe self-reporting of asthma frequently leads to patient misidentification in epidemiological studies. Strategies combining the triangulation of data sources may help to improve the identification of people with asthma. We aimed to combine information from the self-reporting of asthma, medication use and symptoms to identify asthma patterns in the users of an mHealth app.We studied MASK-air® users who reported their daily asthma symptoms (assessed by a 0-100 visual analogue scale - "VAS Asthma") at least three times (either in three different months or in any period). K-means cluster analysis methods were applied to identify asthma patterns based on: (i) whether the user self-reported asthma; (ii) whether the user reported asthma medication use and (iii) VAS asthma. Clusters were compared by the number of medications used, VAS asthma levels and Control of Asthma and Allergic Rhinitis Test (CARAT) levels.METHODSWe studied MASK-air® users who reported their daily asthma symptoms (assessed by a 0-100 visual analogue scale - "VAS Asthma") at least three times (either in three different months or in any period). K-means cluster analysis methods were applied to identify asthma patterns based on: (i) whether the user self-reported asthma; (ii) whether the user reported asthma medication use and (iii) VAS asthma. Clusters were compared by the number of medications used, VAS asthma levels and Control of Asthma and Allergic Rhinitis Test (CARAT) levels.We assessed a total of 8,075 MASK-air® users. The main clustering approach resulted in the identification of seven groups. These groups were interpreted as probable: (i) severe/uncontrolled asthma despite treatment (11.9-16.1% of MASK-air® users); (ii) treated and partly-controlled asthma (6.3-9.7%); (iii) treated and controlled asthma (4.6-5.5%); (iv) untreated uncontrolled asthma (18.2-20.5%); (v) untreated partly-controlled asthma (10.1-10.7%); (vi) untreated controlled asthma (6.7-8.5%) and (vii) no evidence of asthma (33.0-40.2%). This classification was validated in a study of 192 patients enrolled by physicians.FINDINGSWe assessed a total of 8,075 MASK-air® users. The main clustering approach resulted in the identification of seven groups. These groups were interpreted as probable: (i) severe/uncontrolled asthma despite treatment (11.9-16.1% of MASK-air® users); (ii) treated and partly-controlled asthma (6.3-9.7%); (iii) treated and controlled asthma (4.6-5.5%); (iv) untreated uncontrolled asthma (18.2-20.5%); (v) untreated partly-controlled asthma (10.1-10.7%); (vi) untreated controlled asthma (6.7-8.5%) and (vii) no evidence of asthma (33.0-40.2%). This classification was validated in a study of 192 patients enrolled by physicians.We identified seven profiles based on the probability of having asthma and on its level of control. mHealth tools are hypothesis-generating and complement classical epidemiological approaches in identifying patients with asthma.INTERPRETATIONWe identified seven profiles based on the probability of having asthma and on its level of control. mHealth tools are hypothesis-generating and complement classical epidemiological approaches in identifying patients with asthma. AbstractBackgroundThe self-reporting of asthma frequently leads to patient misidentification in epidemiological studies. Strategies combining the triangulation of data sources may help to improve the identification of people with asthma. We aimed to combine information from the self-reporting of asthma, medication use and symptoms to identify asthma patterns in the users of an mHealth app. MethodsWe studied MASK-air® users who reported their daily asthma symptoms (assessed by a 0-100 visual analogue scale – “VAS Asthma”) at least three times (either in three different months or in any period). K-means cluster analysis methods were applied to identify asthma patterns based on: (i) whether the user self-reported asthma; (ii) whether the user reported asthma medication use and (iii) VAS asthma. Clusters were compared by the number of medications used, VAS asthma levels and Control of Asthma and Allergic Rhinitis Test (CARAT) levels. FindingsWe assessed a total of 8,075 MASK-air® users. The main clustering approach resulted in the identification of seven groups. These groups were interpreted as probable: (i) severe/uncontrolled asthma despite treatment (11.9-16.1% of MASK-air® users); (ii) treated and partly-controlled asthma (6.3-9.7%); (iii) treated and controlled asthma (4.6-5.5%); (iv) untreated uncontrolled asthma (18.2-20.5%); (v) untreated partly-controlled asthma (10.1-10.7%); (vi) untreated controlled asthma (6.7-8.5%) and (vii) no evidence of asthma (33.0-40.2%). This classification was validated in a study of 192 patients enrolled by physicians. InterpretationWe identified seven profiles based on the probability of having asthma and on its level of control. mHealth tools are hypothesis-generating and complement classical epidemiological approaches in identifying patients with asthma. Background: The self-reporting of asthma frequently leads to patient misidentification in epidemiological studies. Strategies combining the triangulation of data sources may help to improve the identification of people with asthma. We aimed to combine information from the self-reporting of asthma, medication use and symptoms to identify asthma patterns in the users of an mHealth app. Methods: We studied MASK-air® users who reported their daily asthma symptoms (assessed by a 0-100 visual analogue scale – “VAS Asthma”) at least three times (either in three different months or in any period). K-means cluster analysis methods were applied to identify asthma patterns based on: (i) whether the user self-reported asthma; (ii) whether the user reported asthma medication use and (iii) VAS asthma. Clusters were compared by the number of medications used, VAS asthma levels and Control of Asthma and Allergic Rhinitis Test (CARAT) levels. Findings: We assessed a total of 8,075 MASK-air® users. The main clustering approach resulted in the identification of seven groups. These groups were interpreted as probable: (i) severe/uncontrolled asthma despite treatment (11.9-16.1% of MASK-air® users); (ii) treated and partly-controlled asthma (6.3-9.7%); (iii) treated and controlled asthma (4.6-5.5%); (iv) untreated uncontrolled asthma (18.2-20.5%); (v) untreated partly-controlled asthma (10.1-10.7%); (vi) untreated controlled asthma (6.7-8.5%) and (vii) no evidence of asthma (33.0-40.2%). This classification was validated in a study of 192 patients enrolled by physicians. Interpretation: We identified seven profiles based on the probability of having asthma and on its level of control. mHealth tools are hypothesis-generating and complement classical epidemiological approaches in identifying patients with asthma. © 2022 Sociedade Portuguesa de Pneumologia |
| Author | Buhl, R. Bousquet, J. Roche, N. Cruz, A.A. Valiulis, A. Cecchi, L. Brussino, L. Morais-Almeida, M. Samolinski, B. Puggioni, F. Bedbrook, A. Jutel, M. Laune, D. Kupczyk, M. Romantowski, J. Haahtela, T. Nadif, R. Boulet, L.-P. Louis, R. Taborda-Barata, L. Sheikh, A. Bergmann, K.C. de Blay, F. Gemicioglu, B. Klimek, L. Pham-Thi, N. Bosnic-Anticevich, S. Sastre, J. Chaves-Loureiro, C. Pech, J.L. Ohta, K. Zuberbier, T. Anto, J.M. Bonini, M. Brusselle, G. Czarlewski, W. Vandenplas, O. Regateiro, F.S. Fonseca, J.A. Canonica, G.W. Charpin, D. Amaral, R. Ventura, M.T. Papadopoulos, N.G. Sousa-Pinto, B. Yorgancioglu, A. Makela, M. Kvedariene, V. Kuna, P. Papi, A. Sá-Sousa, A. Niedoszytko, M. Shamji, M.H. Suppli Ulrik, C. Usmani, O.S. Scichilone, N. Yeverino, D.R. Larenas-Linnemann, D.E. Joos, G. Devillier, P. Agache, I. |
| Author_xml | – sequence: 1 givenname: J. orcidid: 0000-0002-4061-4766 surname: Bousquet fullname: Bousquet, J. email: jean.bousquet@orange.fr organization: Institute of Allergology, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany – sequence: 2 givenname: B. surname: Sousa-Pinto fullname: Sousa-Pinto, B. organization: MEDCIDS - Department of Community Medicine, Information and Health Decision Sciences; Faculty of Medicine, University of Porto, Porto, Portugal – sequence: 3 givenname: J.M. surname: Anto fullname: Anto, J.M. organization: ISGlobal, Barcelona Institute for Global Health, Barcelona, Spain – sequence: 4 givenname: R. orcidid: 0000-0002-0233-830X surname: Amaral fullname: Amaral, R. organization: MEDCIDS - Department of Community Medicine, Information and Health Decision Sciences; Faculty of Medicine, University of Porto, Porto, Portugal – sequence: 5 givenname: L. surname: Brussino fullname: Brussino, L. organization: Department of Medical Sciences, Allergy and Clinical Immunology Unit, University of Torino & Mauriziano Hospital, Torino, Italy – sequence: 6 givenname: G.W. surname: Canonica fullname: Canonica, G.W. organization: Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy – sequence: 7 givenname: A.A. orcidid: 0000-0002-7403-3871 surname: Cruz fullname: Cruz, A.A. organization: Fundaçao ProAR, Federal University of Bahia and GARD/WHO Planning Group, Salvador, Bahia, Brazil – sequence: 8 givenname: B. orcidid: 0000-0001-5953-4881 surname: Gemicioglu fullname: Gemicioglu, B. organization: Department of Pulmonary Diseases, Istanbul University-Cerrahpasa, Cerrahpasa Faculty of Medicine, Istanbul, Turkey – sequence: 9 givenname: T. surname: Haahtela fullname: Haahtela, T. organization: Skin and Allergy Hospital, Helsinki University Hospital, University of Helsinki, Finland – sequence: 10 givenname: M. orcidid: 0000-0003-0800-7867 surname: Kupczyk fullname: Kupczyk, M. organization: Division of Internal Medicine, Asthma and Allergy, Barlicki University Hospital, Medical University of Lodz, Poland – sequence: 11 givenname: V. surname: Kvedariene fullname: Kvedariene, V. organization: Institute of Clinical medicine, Clinic of Chest diseases and Allergology, Faculty of Medicine, Vilnius University and Institute of Biomedical Sciences, Department of Pathology, Faculty of Medicine, Vilnius University, Vilnius, Lithuania – sequence: 12 givenname: D.E. orcidid: 0000-0002-5713-5331 surname: Larenas-Linnemann fullname: Larenas-Linnemann, D.E. organization: Center of Excellence in Asthma and Allergy, Médica Sur Clinical Foundation and Hospital, México City, Mexico – sequence: 13 givenname: R. surname: Louis fullname: Louis, R. organization: Department of Pulmonary Medicine, CHU Liège and GIGA I3 research group, University of Liege, Belgium – sequence: 14 givenname: N. surname: Pham-Thi fullname: Pham-Thi, N. organization: Ecole Polytechnique Palaiseau, IRBA (Institut de Recherche bio-Médicale des Armées), Bretigny, France – sequence: 15 givenname: F. surname: Puggioni fullname: Puggioni, F. organization: Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy – sequence: 16 givenname: F.S. surname: Regateiro fullname: Regateiro, F.S. organization: Allergy and Clinical Immunology Unit, Centro Hospitalar e Universitário de Coimbra, and Coimbra Institute for Clinical and Biomedical Research (ICBR), Faculty of Medicine, University of Coimbra, and Institute of Immunology, Faculty of Medicine, University of Coimbra, Coimbra, Portugal – sequence: 17 givenname: J. surname: Romantowski fullname: Romantowski, J. organization: Department of Allergology, Medical University of Gdańsk, Gdansk, Poland – sequence: 18 givenname: J. surname: Sastre fullname: Sastre, J. organization: Fundacion Jimenez Diaz, CIBERES, Faculty of Medicine, Autonoma University of Madrid, Spain – sequence: 19 givenname: N. surname: Scichilone fullname: Scichilone, N. organization: PROMISE Department, University of Palermo, Palermo, Italy – sequence: 20 givenname: L. surname: Taborda-Barata fullname: Taborda-Barata, L. organization: Department of Immunoallergology, Cova da Beira University Hospital Centre, Covilhã, and UBIAir - Clinical & Experimental Lung Centre, and CICS-UBI Health Sciences Research Centre, University of Beira Interior, Covilhã, Portugal – sequence: 21 givenname: M.T. surname: Ventura fullname: Ventura, M.T. organization: Unit of Geriatric Immunoallergology, University of Bari Medical School, Bari, Italy – sequence: 22 givenname: I. surname: Agache fullname: Agache, I. organization: Transylvania University Brasov, Brasov, Romania – sequence: 23 givenname: A. surname: Bedbrook fullname: Bedbrook, A. organization: ARIA, Montpellier, France – sequence: 24 givenname: K.C. surname: Bergmann fullname: Bergmann, K.C. organization: Institute of Allergology, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany – sequence: 25 givenname: S. surname: Bosnic-Anticevich fullname: Bosnic-Anticevich, S. organization: Quality Use of Respiratory Medicine Group, Woolcock Institute of Medical Research, The University of Sydney, and Sydney Local Health District, Sydney, NSW, Australia – sequence: 26 givenname: M. surname: Bonini fullname: Bonini, M. organization: Department of Cardiovascular and Thoracic Sciences, Università Cattolica del Sacro Cuore, Rome, Italy – sequence: 27 givenname: L.-P. surname: Boulet fullname: Boulet, L.-P. organization: Quebec Heart and Lung Institute, Laval University, Québec City, Quebec, Canada – sequence: 28 givenname: G. surname: Brusselle fullname: Brusselle, G. organization: Dept of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium – sequence: 29 givenname: R. surname: Buhl fullname: Buhl, R. organization: Dept of Pulmonary Medicine, Mainz University Hospital, Mainz, Germany – sequence: 30 givenname: L. surname: Cecchi fullname: Cecchi, L. organization: SOS Allergology and Clinical Immunology, USL Toscana Centro, Prato, Italy – sequence: 31 givenname: D. surname: Charpin fullname: Charpin, D. organization: Clinique des bronches, allergie et sommeil, Hôpital Nord, Marseille, France – sequence: 32 givenname: C. surname: Chaves-Loureiro fullname: Chaves-Loureiro, C. organization: Pneumology Unit, Hospitais da Universidade de Coimbra, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal – sequence: 33 givenname: W. surname: Czarlewski fullname: Czarlewski, W. organization: Medical Consulting Czarlewski, Levallois, France – sequence: 34 givenname: F. surname: de Blay fullname: de Blay, F. organization: Allergy Division, Chest Disease Department, University Hospital of Strasbourg, and Federation of translational medicine, University of Strasbourg, Strasbourg, France – sequence: 35 givenname: P. surname: Devillier fullname: Devillier, P. organization: VIM Suresnes, UMR 0892, Pôle des Maladies des Voies Respiratoires, Hôpital Foch, Université Paris-Saclay, Suresnes, France – sequence: 36 givenname: G. surname: Joos fullname: Joos, G. organization: Dept of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium – sequence: 37 givenname: M. surname: Jutel fullname: Jutel, M. organization: Department of Clinical Immunology, Wrocław Medical University, and ALL-MED Medical Research Institute, Wroclaw, Poland – sequence: 38 givenname: L. surname: Klimek fullname: Klimek, L. organization: Department of Otolaryngology, Head and Neck Surgery, Universitätsmedizin Mainz, Mainz, and Center for Rhinology and Allergology, Wiesbaden, Germany – sequence: 39 givenname: P. surname: Kuna fullname: Kuna, P. organization: Division of Internal Medicine, Asthma and Allergy, Barlicki University Hospital, Medical University of Lodz, Poland – sequence: 40 givenname: D. surname: Laune fullname: Laune, D. organization: KYomed INNOV, Montpellier, France – sequence: 41 givenname: J.L. surname: Pech fullname: Pech, J.L. organization: University of Guadalajara, Guadalajara, Mexico – sequence: 42 givenname: M. surname: Makela fullname: Makela, M. organization: Skin and Allergy Hospital, Helsinki University Hospital, University of Helsinki, Finland – sequence: 43 givenname: M. surname: Morais-Almeida fullname: Morais-Almeida, M. organization: Allergy Center, CUF Descobertas Hospital, Lisbon, Portugal – sequence: 44 givenname: R. surname: Nadif fullname: Nadif, R. organization: Université Paris-Saclay, UVSQ, Univ. Paris-Sud, and Inserm, Equipe d'Epidémiologie Respiratoire Intégrative, CESP, Villejuif, France – sequence: 45 givenname: M. surname: Niedoszytko fullname: Niedoszytko, M. organization: Department of Allergology, Medical University of Gdańsk, Gdansk, Poland – sequence: 46 givenname: K. surname: Ohta fullname: Ohta, K. organization: National Hospital Organization, Tokyo National Hospital, and JATA Fukujuji Hospital, Tokyo, Japan – sequence: 47 givenname: N.G. surname: Papadopoulos fullname: Papadopoulos, N.G. organization: Allergy Department, 2nd Pediatric Clinic, University of Athens, Athens, Greece – sequence: 48 givenname: A. surname: Papi fullname: Papi, A. organization: Respiratory Medicine, Department of Translational Medicine, University of Ferrara, Ferrara, Italy – sequence: 49 givenname: D.R. surname: Yeverino fullname: Yeverino, D.R. organization: Allergy and Clinical Immunology Department, Hospital Universitario de Puebla, Puebla, Mexico – sequence: 50 givenname: N. surname: Roche fullname: Roche, N. organization: Pneumologie, AP-HP Centre Université de Paris Cité, Hôpital Cochin, Paris and UMR 1016, Institut Cochin, Paris, France – sequence: 51 givenname: A. surname: Sá-Sousa fullname: Sá-Sousa, A. organization: MEDCIDS - Department of Community Medicine, Information and Health Decision Sciences; Faculty of Medicine, University of Porto, Porto, Portugal – sequence: 52 givenname: B. surname: Samolinski fullname: Samolinski, B. organization: Department of Prevention of Environmental Hazards, Allergology and Immunology, Medical University of Warsaw, Poland – sequence: 53 givenname: M.H. surname: Shamji fullname: Shamji, M.H. organization: National Heart and Lung Institute, Imperial College London, and NIHR Imperial Biomedical Research Centre, London, UK – sequence: 54 givenname: A. surname: Sheikh fullname: Sheikh, A. organization: Usher Institute, The University of Edinburgh, Edinburgh, UK – sequence: 55 givenname: C. surname: Suppli Ulrik fullname: Suppli Ulrik, C. organization: Department of Respiratory Medicine, Copenhagen University Hospital-Hvidovre, and Institute of Cinical Medicine, University of Copenhagen, Denmark – sequence: 56 givenname: O.S. surname: Usmani fullname: Usmani, O.S. organization: National Heart and Lung Institute (NHLI), Imperial College London & Royal Brompton Hospital, Airways Disease Section, London, UK – sequence: 57 givenname: A. surname: Valiulis fullname: Valiulis, A. organization: Institute of Clinical Medicine and Institute of Health Sciences,Vilnius, and Medical Faculty of Vilnius University, Vilnius, Lithuania – sequence: 58 givenname: O. surname: Vandenplas fullname: Vandenplas, O. organization: Department of Chest Medicine, Centre Hospitalier Universitaire UCL, Namur, and Université Catholique de Louvain, Yvoir, Belgium – sequence: 59 givenname: A. surname: Yorgancioglu fullname: Yorgancioglu, A. organization: Department of Pulmonary Diseases, Celal Bayar University, Faculty of Medicine, Manisa, Turkey – sequence: 60 givenname: T. surname: Zuberbier fullname: Zuberbier, T. organization: Institute of Allergology, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany – sequence: 61 givenname: J.A. surname: Fonseca fullname: Fonseca, J.A. organization: MEDCIDS - Department of Community Medicine, Information and Health Decision Sciences; Faculty of Medicine, University of Porto, Porto, Portugal |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36428213$$D View this record in MEDLINE/PubMed https://hal.science/hal-04260452$$DView record in HAL |
| BookMark | eNqVkt2K1DAYhousuOu6dyCSQz2YMX9NOyILw6LO4IoHu-fha5rOZEybmqQjc1NehFdmOt0VFWQRCg1f3_dpSJ6n2UnnOp1lzwmeE0zE6928H2zr9JxiStNojnH-KDujOSMzzFlx8tv6NLsIYYcxpulhJXmSnTLBaUkJO8u6da27aBqjIBrXoeqAlB1C1B5BB_YQTECuQX36mnIBfTNxiyDEbQspUKMOAlgUDm0fXRvQEEy3QXGr0aflzccZGP_jO2pXGuxY6_tn2eMGbNAXd-_z7Pb9u9ur1ez684f11fJ6poTAcUY5V5zXDc1JDazCoqjLqhSNqItFDVCzipa8Eo1SCwoNFKUSqioYWWBKFMHsPFtP2NrBTvbetOAP0oGRx4HzGwk-GmW11DivoChwniC8KXhZ8qbKCSVpI6zhKrHYxLJGb3TqVkbu6RF2XA82wZSstKRUlJJhWgqWWq-m1hbsHxtYLa_lOMOcCsxzuicp-3LK9t59HXSIsjVBaWuh024IkhYc55hxlqfoi7voULW6_kW-v9AUeDMFlHcheN1IZeLxaqMHYyXBchRIplM5CiRHgcZpEiiV-V_le_4DtcupptON7o32Mqhki9K18VrFdObmfwHKmi4pab_ogw47N_jkYpBEBiqxvBnVHs2mo9E5HQFv_w14-P8_AQZDCWg |
| CitedBy_id | crossref_primary_10_1111_all_15880 crossref_primary_10_1111_pai_14134 crossref_primary_10_2147_JAA_S281439 crossref_primary_10_1002_clt2_12358 crossref_primary_10_1080_25310429_2025_2532980 crossref_primary_10_1016_j_jaip_2024_06_040 crossref_primary_10_1111_all_15842 crossref_primary_10_1111_pai_14080 crossref_primary_10_1016_j_bjorl_2024_101500 crossref_primary_10_1016_j_pulmoe_2023_07_004 crossref_primary_10_1080_25310429_2024_2419216 crossref_primary_10_1097_ACI_0000000000001027 crossref_primary_10_1016_j_jaip_2024_03_024 crossref_primary_10_1016_j_alit_2024_12_007 crossref_primary_10_1016_j_pulmoe_2022_12_001 |
| Cites_doi | 10.1186/s13601-020-00342-x 10.1093/ije/28.3.409 10.1111/all.13697 10.1038/s41598-020-72060-0 10.1164/rccm.201808-1543OC 10.1186/2045-7022-2-16 10.1111/all.13448 10.1183/20734735.0362-2018 10.3109/02770903.2014.930480 10.1016/j.rmr.2019.08.003 10.1111/all.13218 10.1002/clt2.12062 10.1164/rccm.200711-1754OC 10.1164/rccm.201804-0682CI 10.4187/respcare.04553 10.1111/j.1398-9995.2009.02310.x 10.1111/all.15248 10.1111/all.14415 10.2147/JMDH.S104807 10.1111/all.13670 10.1111/all.14314 10.1111/cea.13333 10.1016/j.jaip.2021.09.012 10.1016/j.jclinepi.2005.03.019 |
| ContentType | Journal Article |
| Copyright | 2022 Sociedade Portuguesa de Pneumologia Sociedade Portuguesa de Pneumologia Copyright © 2022 Sociedade Portuguesa de Pneumologia. Published by Elsevier España, S.L.U. All rights reserved. Distributed under a Creative Commons Attribution 4.0 International License |
| Copyright_xml | – notice: 2022 Sociedade Portuguesa de Pneumologia – notice: Sociedade Portuguesa de Pneumologia – notice: Copyright © 2022 Sociedade Portuguesa de Pneumologia. Published by Elsevier España, S.L.U. All rights reserved. – notice: Distributed under a Creative Commons Attribution 4.0 International License |
| DBID | 6I. AAFTH AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 1XC BXJBU IHQJB VOOES JLOSS Q33 DOA |
| DOI | 10.1016/j.pulmoe.2022.10.005 |
| DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic Hyper Article en Ligne (HAL) HAL-SHS: Archive ouverte en Sciences de l'Homme et de la Société HAL-SHS: Archive ouverte en Sciences de l'Homme et de la Société (Open Access) Hyper Article en Ligne (HAL) (Open Access) Université de Liège - Open Repository and Bibliography (ORBI) (Open Access titles only) Université de Liège - Open Repository and Bibliography (ORBI) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 2531-0437 1099-0496 |
| EndPage | 305 |
| ExternalDocumentID | oai_doaj_org_article_e05ba770578c4f74884fb51216603f4c oai_orbi_ulg_ac_be_2268_302863 oai:HAL:hal-04260452v1 36428213 10_1016_j_pulmoe_2022_10_005 S2531043722002525 1_s2_0_S2531043722002525 |
| Genre | Journal Article |
| GroupedDBID | .1- .FO 0R~ 1P~ 65R AAEDW AALRI AAXUO AAYWO ABMAC ACLIJ ACVFH ADBBV ADCNI ADVLN AEUPX AEXQZ AFPUW AFRHN AFTJW AIGII AITUG AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ BCNDV EBS EJD FDB GROUPED_DOAJ M4Z OK1 ROL SSZ TDBHL Z5R AACTN AFCTW NCXOZ 0SF 6I. AAFTH AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 --- .3N .GA .GJ .Y3 05W 10A 123 1L6 1OB 1OC 1XC 1ZS 31~ 33P 3SF 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHQN AAIPD AAMMB AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABEML ABIJN ABJNI ABLJU ABOCM ABPPZ ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCZN ACGFS ACGOF ACMXC ACPOU ACRPL ACSCC ACXBN ACXQS ACYXJ ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZMN AEFGJ AEIGN AEIMD AENEX AEUYR AEYWJ AFBPY AFFNX AFFPM AFGKR AFWVQ AFZJQ AGHNM AGQPQ AGXDD AGYGG AHBTC AHMBA AIACR AIDQK AIDYY AIQQE AITYG AIURR ALAGY ALUQN ALVPJ AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BXJBU BY8 C45 CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 DUUFO EMOBN F00 F01 F04 F5P FEDTE FUBAC G-S G.N GNP GODZA H.X HBH HF~ HGLYW HHY HHZ HVGLF HZ~ IHQJB IX1 J0M JPC KBYEO KQQ LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M65 MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ NNB O66 O8X O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 QRW R.K RIWAO RJQFR RX1 RYL SAMSI SUPJJ TEORI UB1 V2E VOOES W8V W99 WBKPD WHWMO WIB WIH WIJ WIK WJL WOHZO WQJ WVDHM WXI WXSBR XG1 XPP XV2 ZGI ZXP ZZTAW ~IA ~WT JLOSS Q33 AQTUD |
| ID | FETCH-LOGICAL-c660t-244c44df251da3b067d8b86f6d79daad3b284b6fcc92afa78c6cb7319021c103 |
| IEDL.DBID | DOA |
| ISICitedReferencesCount | 5 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001035277500001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 2531-0437 2531-0429 8755-6863 |
| IngestDate | Mon Nov 10 19:22:54 EST 2025 Sat Nov 29 01:22:13 EST 2025 Sat Nov 29 14:59:14 EST 2025 Thu Sep 04 18:40:16 EDT 2025 Mon Jul 21 06:00:49 EDT 2025 Sat Nov 29 08:03:34 EST 2025 Tue Nov 18 22:32:38 EST 2025 Sat Jun 10 15:31:34 EDT 2023 Tue Feb 25 19:53:33 EST 2025 Tue Aug 26 18:40:54 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 4 |
| Keywords | Cluster analysis Control Treatment Rhinitis Asthma |
| Language | English |
| License | This is an open access article under the CC BY-NC-ND license. Copyright © 2022 Sociedade Portuguesa de Pneumologia. Published by Elsevier España, S.L.U. All rights reserved. Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0 |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c660t-244c44df251da3b067d8b86f6d79daad3b284b6fcc92afa78c6cb7319021c103 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 scopus-id:2-s2.0-85142526120 |
| ORCID | 0000-0001-5953-4881 0000-0002-0233-830X 0000-0002-7403-3871 0000-0002-5713-5331 0000-0002-4061-4766 0000-0003-0800-7867 0000-0003-4938-9339 |
| OpenAccessLink | https://doaj.org/article/e05ba770578c4f74884fb51216603f4c |
| PMID | 36428213 |
| PQID | 2740503435 |
| PQPubID | 23479 |
| PageCount | 14 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_e05ba770578c4f74884fb51216603f4c liege_orbi_v2_oai_orbi_ulg_ac_be_2268_302863 hal_primary_oai_HAL_hal_04260452v1 proquest_miscellaneous_2740503435 pubmed_primary_36428213 crossref_citationtrail_10_1016_j_pulmoe_2022_10_005 crossref_primary_10_1016_j_pulmoe_2022_10_005 elsevier_sciencedirect_doi_10_1016_j_pulmoe_2022_10_005 elsevier_clinicalkeyesjournals_1_s2_0_S2531043722002525 elsevier_clinicalkey_doi_10_1016_j_pulmoe_2022_10_005 |
| PublicationCentury | 2000 |
| PublicationDate | 2023-07-01 |
| PublicationDateYYYYMMDD | 2023-07-01 |
| PublicationDate_xml | – month: 07 year: 2023 text: 2023-07-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | Spain |
| PublicationPlace_xml | – name: Spain |
| PublicationTitle | Pediatric pulmonology |
| PublicationTitleAlternate | Pulmonology |
| PublicationYear | 2023 |
| Publisher | Elsevier España, S.L.U Wiley Elsevier Espana S.L.U Taylor & Francis Group |
| Publisher_xml | – name: Elsevier España, S.L.U – name: Wiley – name: Elsevier Espana S.L.U – name: Taylor & Francis Group |
| References | Zhu, McKnight, Stergachis, Daling, Levine (bib0002) 1999; 28 Althubaiti (bib0001) 2016; 9 2021. Bousquet, Devillier, Anto (bib0013) 2018; 73 Menditto, Costa, Midao (bib0014) 2019; 49 Fonseca, Nogueira-Silva, Morais-Almeida (bib0016) 2012; 2 Lemonnier, Melen, Jiang (bib0025) 2020; 75 Bousquet, Agache, Aliberti (bib0015) 2017; 73 Sousa-Pinto, Eklund, Pfaar (bib0024) 2021; 11 Amaral, Bousquet, Pereira (bib0010) 2019; 74 Burnett, Vardiman, Deckert, Ward, Sharpe (bib0003) 2016; 61 Haldar, Pavord, Shaw (bib0008) 2008; 178 Tibble, Chan, Mitchell (bib0012) 2020; 10 Fonseca, Nogueira-Silva, Morais-Almeida (bib0019) 2010; 65 Toren, Palmqvist, Lowhagen, Balder, Tunsater (bib0006) 2006; 59 Boudier, Chanoine, Accordini (bib0009) 2019; 74 Sastre, Del Cuvillo, Colas (bib0022) 2020; 75 Wu, Bang, Bleecker (bib0011) 2019; 199 Aaron, Boulet, Reddel, Gershon (bib0005) 2018; 198 Laune, Arnavielhe, Viart (bib0018) 2019; 36 Mirabelli, Beavers, Flanders, Chatterjee (bib0007) 2014; 51 Bedard, Basagana, Anto (bib0020) 2020; 10 Kavanagh, Jackson, Kent (bib0004) 2019; 15 Sousa-Pinto, Fonseca, Gemicioglu (bib0021) 2022; 77 GINA report 2021. Sousa-Pinto, Sa-Sousa, Amaral (bib0023) 2022; 10 e_1_3_2_20_1 e_1_3_2_21_1 e_1_3_2_22_1 e_1_3_2_23_1 e_1_3_2_24_1 e_1_3_2_25_1 e_1_3_2_26_1 e_1_3_2_16_1 e_1_3_2_9_1 e_1_3_2_17_1 e_1_3_2_8_1 e_1_3_2_18_1 e_1_3_2_7_1 e_1_3_2_19_1 e_1_3_2_2_1 e_1_3_2_10_1 e_1_3_2_11_1 e_1_3_2_6_1 e_1_3_2_12_1 e_1_3_2_5_1 e_1_3_2_13_1 e_1_3_2_4_1 e_1_3_2_14_1 e_1_3_2_3_1 e_1_3_2_15_1 |
| References_xml | – volume: 73 start-page: 1622 year: 2018 end-page: 1631 ident: bib0013 article-title: Daily allergic multimorbidity in rhinitis using mobile technology: a novel concept of the MASK study publication-title: Allergy – volume: 11 start-page: e12062 year: 2021 ident: bib0024 article-title: Validity, reliability, and responsiveness of daily monitoring visual analog scales in MASK-air(R) publication-title: Clin Transl Allergy – volume: 28 start-page: 409 year: 1999 end-page: 417 ident: bib0002 article-title: Comparison of self-report data and medical records data: results from a case-control study on prostate cancer publication-title: Int J Epidemiol – volume: 15 start-page: e20 year: 2019 end-page: e27 ident: bib0004 article-title: Over- and under-diagnosis in asthma publication-title: Breathe – volume: 61 start-page: 897 year: 2016 end-page: 901 ident: bib0003 article-title: Perception of exercise-induced bronchoconstriction in college athletes publication-title: Respir Care – volume: 36 start-page: 1019 year: 2019 end-page: 1031 ident: bib0018 article-title: [Adaptation of the general data protection regulation (GDPR) to a smartphone app for rhinitis and asthma (MASK-air(R))] publication-title: Rev Mal Respir – volume: 77 start-page: 1600 year: 2022 end-page: 1602 ident: bib0021 article-title: Patient-reported outcome measures (PROMs) using the MASK-air(R) app in severe asthma publication-title: Allergy – volume: 10 start-page: 14999 year: 2020 ident: bib0012 article-title: A data-driven typology of asthma medication adherence using cluster analysis publication-title: Sci Rep – volume: 198 start-page: 1012 year: 2018 end-page: 1020 ident: bib0005 article-title: Underdiagnosis and overdiagnosis of asthma publication-title: Am J Respir Crit Care Med – volume: 2 start-page: 16 year: 2012 ident: bib0016 article-title: Control of allergic rhinitis and asthma test (CARAT) can be used to assess individual patients over time publication-title: Clin Transl Allergy – volume: 10 start-page: 62 year: 2020 ident: bib0020 article-title: Treatment of allergic rhinitis during and outside the pollen season using mobile technology. A MASK study publication-title: Clin Transl Allergy – volume: 74 start-page: 698 year: 2019 end-page: 708 ident: bib0010 article-title: Disentangling the heterogeneity of allergic respiratory diseases by latent class analysis reveals novel phenotypes publication-title: Allergy – volume: 51 start-page: 956 year: 2014 end-page: 963 ident: bib0007 article-title: Reliability in reporting asthma history and age at asthma onset publication-title: J Asthma – volume: 199 start-page: 1358 year: 2019 end-page: 1367 ident: bib0011 article-title: Multiview cluster analysis identifies variable corticosteroid response phenotypes in severe asthma publication-title: Am J Respir Crit Care Med – reference: GINA report 2021. – volume: 65 start-page: 1042 year: 2010 end-page: 1048 ident: bib0019 article-title: Validation of a questionnaire (CARAT10) to assess rhinitis and asthma in patients with asthma publication-title: Allergy – volume: 74 start-page: 953 year: 2019 end-page: 963 ident: bib0009 article-title: Data-driven adult asthma phenotypes based on clinical characteristics are associated with asthma outcomes twenty years later publication-title: Allergy – volume: 73 start-page: 77 year: 2017 end-page: 92 ident: bib0015 article-title: Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA-ARIA) - reference site twinning (EIP on AHA) publication-title: Allergy – volume: 178 start-page: 218 year: 2008 end-page: 224 ident: bib0008 article-title: Cluster analysis and clinical asthma phenotypes publication-title: Am J Respir Crit Care Med – volume: 75 start-page: 3248 year: 2020 end-page: 3260 ident: bib0025 article-title: A novel whole blood gene expression signature for asthma, dermatitis, and rhinitis multimorbidity in children and adolescents publication-title: Allergy – volume: 59 start-page: 90 year: 2006 end-page: 93 ident: bib0006 article-title: Self-reported asthma was biased in relation to disease severity while reported year of asthma onset was accurate publication-title: J Clin Epidemiol – volume: 49 start-page: 442 year: 2019 end-page: 460 ident: bib0014 article-title: Adherence to treatment in allergic rhinitis using mobile technology. The MASK study publication-title: Clin Exp Allergy – volume: 75 start-page: 2958 year: 2020 end-page: 2961 ident: bib0022 article-title: Validation of the MASK-air App for assessment of allergic rhinitis publication-title: Allergy – volume: 10 start-page: 343 year: 2022 end-page: 345 ident: bib0023 article-title: Assessment of the control of allergic rhinitis and asthma test (CARAT) using MASK-air publication-title: J Allergy Clin Immunol Pract – reference: . 2021. – volume: 9 start-page: 211 year: 2016 end-page: 217 ident: bib0001 article-title: Information bias in health research: definition, pitfalls, and adjustment methods publication-title: J Multidiscip Healthc – ident: e_1_3_2_21_1 doi: 10.1186/s13601-020-00342-x – ident: e_1_3_2_3_1 doi: 10.1093/ije/28.3.409 – ident: e_1_3_2_10_1 doi: 10.1111/all.13697 – ident: e_1_3_2_13_1 doi: 10.1038/s41598-020-72060-0 – ident: e_1_3_2_12_1 doi: 10.1164/rccm.201808-1543OC – ident: e_1_3_2_17_1 doi: 10.1186/2045-7022-2-16 – ident: e_1_3_2_14_1 doi: 10.1111/all.13448 – ident: e_1_3_2_5_1 doi: 10.1183/20734735.0362-2018 – ident: e_1_3_2_8_1 doi: 10.3109/02770903.2014.930480 – ident: e_1_3_2_19_1 doi: 10.1016/j.rmr.2019.08.003 – ident: e_1_3_2_16_1 doi: 10.1111/all.13218 – ident: e_1_3_2_18_1 – ident: e_1_3_2_25_1 doi: 10.1002/clt2.12062 – ident: e_1_3_2_9_1 doi: 10.1164/rccm.200711-1754OC – ident: e_1_3_2_6_1 doi: 10.1164/rccm.201804-0682CI – ident: e_1_3_2_4_1 doi: 10.4187/respcare.04553 – ident: e_1_3_2_20_1 doi: 10.1111/j.1398-9995.2009.02310.x – ident: e_1_3_2_22_1 doi: 10.1111/all.15248 – ident: e_1_3_2_23_1 doi: 10.1111/all.14415 – ident: e_1_3_2_2_1 doi: 10.2147/JMDH.S104807 – ident: e_1_3_2_11_1 doi: 10.1111/all.13670 – ident: e_1_3_2_26_1 doi: 10.1111/all.14314 – ident: e_1_3_2_15_1 doi: 10.1111/cea.13333 – ident: e_1_3_2_24_1 doi: 10.1016/j.jaip.2021.09.012 – ident: e_1_3_2_7_1 doi: 10.1016/j.jclinepi.2005.03.019 |
| SSID | ssj0002002381 ssib044757603 ssj0009991 |
| Score | 2.478714 |
| Snippet | The self-reporting of asthma frequently leads to patient misidentification in epidemiological studies. Strategies combining the triangulation of data sources... AbstractBackgroundThe self-reporting of asthma frequently leads to patient misidentification in epidemiological studies. Strategies combining the triangulation... Background: The self-reporting of asthma frequently leads to patient misidentification in epidemiological studies. Strategies combining the triangulation of... Background The self-reporting of asthma frequently leads to patient misidentification in epidemiological studies. Strategies combining the triangulation of... |
| SourceID | doaj liege hal proquest pubmed crossref elsevier |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 292 |
| SubjectTerms | Asthma Asthma - diagnosis Asthma - epidemiology Cardiovascular & respiratory systems Cluster analysis Control Human health sciences Humanities and Social Sciences Humans Internal Medicine Life Sciences Mobile Applications Pulmonary/Respiratory Research Design Rhinitis Rhinitis, Allergic - diagnosis Rhinitis, Allergic - epidemiology Sciences de la santé humaine Systèmes cardiovasculaire & respiratoire Treatment |
| Title | Identification by cluster analysis of patients with asthma and nasal symptoms using the MASK-air® mHealth app |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S2531043722002525 https://www.clinicalkey.es/playcontent/1-s2.0-S2531043722002525 https://dx.doi.org/10.1016/j.pulmoe.2022.10.005 https://www.ncbi.nlm.nih.gov/pubmed/36428213 https://www.proquest.com/docview/2740503435 https://hal.science/hal-04260452 https://orbi.uliege.be/handle/2268/302863 https://doaj.org/article/e05ba770578c4f74884fb51216603f4c |
| Volume | 29 |
| WOSCitedRecordID | wos001035277500001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2531-0437 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0002002381 issn: 2531-0437 databaseCode: DOA dateStart: 20180101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 2531-0437 dateEnd: 99991231 omitProxy: false ssIdentifier: ssib044757603 issn: 2531-0429 databaseCode: M~E dateStart: 20180101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVWIB databaseName: Wiley Online Library - Journals customDbUrl: eissn: 2531-0437 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0009991 issn: 2531-0437 databaseCode: DRFUL dateStart: 19970101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1fb9MwELfYhhAvE_8pfyqDeCSQ2EnsPBZYNYl1QmxIfbNsJ9k6tWnUtJX2so_Eh-CTcec41SqBygNvjWU78t2vd-f4_DtC3iV5UYQpM0FYcgMbFJkFJitkIDMkr2K55Va6YhPi9FSOx9m3W6W-MCespQduBfexCBOjhYCwQtq4FIC3uDTgpaI0DXkZW7S-EPXc2kwBkpDFTqT-fPHKHbc534SV5gB0AVrh7h6dS_aqV9PZHFkzGfvgkr2SLT_l6Py33NXeJeZNHkzxZPvvwalzUsMH5NBHl3TQruohuVNUj8i9kT8_f0yq9l5u6T_UUXNN7XSFXAlUe3YSOi-pJ1ttKH6lpbpZXs40dMhppRuYvrme1cv5rKGYNH9BIYSko8HZ10BPFr9-0ll7s4nqun5CzodH55-PA19xIbAgzmUAvt7GcV5C0JNrbsCT5dLItExzkeVa59yAN8PrQTZjutSgktQaAf9iiBRsFPKnZL-aV8VzQuPICp0k1sqI44zaxFkO4QIrLGAgjXqEd-JV1rORY1GMqerSzq5UqxSFSsFWUEqPBJtRdcvGsaP_J9Tcpi9yabsGQJjyCFO7ENYjSad31V1XBQMLE012vFz8aVzReCvRqEg1TIXqDDGJHFMMYZqwrZE-EGoDnH9451sA5tZ6jwcnCttcLYI4YWuQ_XuHW5CCmag1c93c79UUxGKVgTlZKhWH4DPlPfKmg7cC24MHSroq5qtGMREjnRBE3D3yrMX95tUcN7Ys4i_-hwpekvuwSN6mSb8i-8vFqnhN7tr1ctIs-mRPjGXfGYA-OfjyffjjBJ5GN0e_AdqDWvU |
| linkProvider | Directory of Open Access Journals |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Identification+by+cluster+analysis+of+patients+with+asthma+and+nasal+symptoms+using+the+MASK-air%C2%AE+mHealth+app&rft.jtitle=Pulmonology&rft.au=Bousquet%2C+J.&rft.au=Sousa-Pinto%2C+B.&rft.au=Anto%2C+J.M.&rft.au=Amaral%2C+R.&rft.date=2023-07-01&rft.pub=Elsevier+Espa%C3%B1a%2C+S.L.U&rft.issn=2531-0437&rft.eissn=2531-0437&rft.volume=29&rft.issue=4&rft.spage=292&rft.epage=305&rft_id=info:doi/10.1016%2Fj.pulmoe.2022.10.005&rft.externalDocID=S2531043722002525 |
| thumbnail_m | http://cvtisr.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F25310437%2FS2531043723X0004X%2Fcov150h.gif |